Decentralised Procedure Process Timetable

The decentralised procedure (DCP) is the European Union-wide procedure for authorising medicines in more than one European Union Member State in parallel. It can be used for medicines that do not need to be authorised via the centralised procedure and have not already been authorised in any Member State. The procedure falls under the Directive 2004/27/EC.

In the decentralised procedure, the applicant chooses one country as the reference Member State when making its application for marketing authorisation. The marketing authorisation in all chosen Member States is received simultaneously, enabling simultaneous marketing of the medicine and reducing the administrative and regulatory burden.

Asphalion Services

Access a comprehensive overview of our company through our Corporate Presentation. This document provides detailed insights into our mission, vision, and values, along with an overview of our core business areas, growth strategies, recent achievements, and future outlook.

Designed to offer a clear and concise perspective of who we are, what we do, and how we create value for our clients, partners, this presentation serves as an essential resource for understanding our organization.

Download it now to learn more about our value proposition, our team, and the opportunities we are driving.

Poster | The new key player in Digital Transformation and Pharmacovigilance

Digital tools in pharmacovigilance are increasingly valued for their transformative potential. Integrating these tools requires a strategic approach merging technological capability with regulatory compliance.